Description: Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 1MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 1MIU include Slurred speech, upset stomach, gastrointestinal disturbance, generalized itching, red spots or bumps, increased blood urea nitrogen, increased creatinine level in blood, decreased creatinine clearance, respiratory distress, apnea (absence of breathing), renal toxicity, decreased urinary volume, dizziness, paresthesia (tingling or pricking sensation), vertigo, rash, and fever. Taj Pharma is a top-tier manufacturer and global exporter of Colistimethate Sodium for Injection IP 1MIU, delivering world-class pharmaceutical solutions from Vapi, Gujarat, India. Designed for critically ill patients, this powerful antibiotic is widely used in hospitals to combat severe infections caused by multidrug-resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii. Taj Pharma’s Colistimethate Sodium is formulated under WHO-GMP certified facilities, ensuring unmatched purity, safety, and therapeutic effectiveness. Trusted across India, Africa, the Middle East, and LATAM, Taj Pharma’s commitment to quality and regulatory compliance makes it a preferred partner for hospitals, pharmacies, and healthcare institutions. This injection is administered intravenously under medical supervision, and dosing is carefully tailored to the patient’s condition, especially in cases of renal impairment. Taj Pharma also provides PCD Pharma Franchise and third-party manufacturing opportunities, offering strong marketing support and seamless distribution. With a proven track record in exports, competitive pricing, and adherence to international standards, Taj Pharma stands as a reliable name in the global pharmaceutical industry. Choose Taj Pharma for consistent supply, best pricing, and high-quality Colistimethate Sodium for Injection IP 1MIU. Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Colistimethate Sodium for Injection IP 1MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 252 KB
